Physician
Providence Health & Services - Oregon
Providence Health & Services - Oregon was paid $20.93M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.
33Billing provider infoPROVIDENCE HEALTH & SERVICES - OREGON
MEDFORD, OR 97504
MEDFORD, OR 97504
33aNPI1689755670assigned 10/18/2006
33bProvider typeAnesthesiology Physician
28Total paid$20.93M
24GClaims267,858
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Oregon
Rank by total paid#3 of 43
Median peer was paid$94K
This provider vs. median223×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,622 | $2.98M | |
| 2019 | 46,868 | $2.76M | |
| 2020 | 32,940 | $2.44M | |
| 2021 | 35,804 | $2.73M | |
| 2022 | 42,386 | $3.60M | |
| 2023 | 37,093 | $3.40M | |
| 2024incomplete | 24,145 | $3.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 28,140 | 24,894 | $6.87M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 34,396 | 30,256 | $5.66M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 25% | 15,334 | 13,810 | $5.15M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.9% | 12,792 | 11,939 | $1.65M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 2,870 | 2,601 | $264K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 5,265 | 4,836 | $227K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,042 | 3,666 | $200K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,422 | 2,285 | $157K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,657 | 2,325 | $84K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 303 | 284 | $69K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 191 | 144 | $63K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 652 | 486 | $54K |
84 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 858 | $47K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,225 | $38K |
| 86900 | <1% | 519 | $31K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 45 | $29K |
| 80053 | Comprehensive metabolic panel | <1% | 32,301 | $28K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,362 | $24K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 378 | $23K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 729 | $22K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 425 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 38,434 | $16K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 26 | $16K |
| 87660 | <1% | 1,000 | $14K | |
| 87510 | <1% | 998 | $14K | |
| 87480 | <1% | 1,001 | $14K | |
| 93990 | <1% | 510 | $11K | |
| 83516 | <1% | 1,308 | $10K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 634 | $10K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 178 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,757 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 84 | $7K |
| 43235 | <1% | 13 | $7K | |
| 87536 | <1% | 152 | $7K | |
| 82728 | <1% | 708 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,049 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 306 | $6K |
| 86803 | <1% | 530 | $5K | |
| 59025 | Fetal non-stress test | <1% | 43 | $5K |
| 86762 | <1% | 505 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 757 | $5K |
| 85027 | <1% | 1,315 | $4K | |
| 87340 | <1% | 551 | $4K | |
| 81001 | <1% | 13,768 | $3K | |
| 95800 | <1% | 26 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 122 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 122 | $3K |
| 80061 | Lipid panel | <1% | 418 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,601 | $3K |
| 82570 | <1% | 675 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $2K |
| 86359 | <1% | 103 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 126 | $2K |
| 84439 | <1% | 279 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 60 | $2K |
| 86361 | <1% | 103 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 152 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 98 | $858.64 |
| 86850 | <1% | 610 | $722.16 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,346 | $525.44 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,338 | $442.97 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,505 | $203.50 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,270 | $189.47 |
| 86140 | <1% | 53 | $162.45 | |
| 85610 | <1% | 497 | $157.61 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,691 | $128.66 |
| 86901 | <1% | 519 | $126.54 | |
| 83690 | <1% | 3,201 | $68.50 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 572 | $45.85 |
| 87641 | <1% | 12 | $28.07 | |
| 80305 | <1% | 288 | $17.17 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 27 | $16.78 |
| 83605 | <1% | 60 | $12.10 | |
| 84484 | <1% | 2,865 | $11.15 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,432 | $10.40 |
| 81025 | <1% | 768 | $10.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,452 | $1.22 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 691 | $0.06 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,740 | $0.00 |
| 84703 | 0% | 102 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 111 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 272 | $0.00 |
| 87070 | 0% | 38 | $0.00 | |
| 83880 | 0% | 45 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 13 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 13 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 19 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 24 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 4,051 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,530 | $0.00 |
| 81003 | 0% | 71 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 94 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 59 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 14 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 20 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Parent organizationPROVIDENCE HEALTH & SERVICES - OREGON
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.